Buys
Open market- Shares
- Avg price
- Total value
Richard I. Steinhart - Chief Financial Officer at BioXcel Therapeutics, Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Chief Financial Officer
- Issuer symbol
- BTAI on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
Richard I. Steinhart - trading volume in the past year for BioXcel Therapeutics, Inc.
Sells
Open market- Shares
- -6,845
- Avg price
- $1.08
- Total value
- -$7,427
Net
Past year- Shares
- -6,845
- Share %
- -100%
- Total value
- -$7,427
Holdings reported by Richard I. Steinhart for BioXcel Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
BioXcel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 26,300
- Estimated value
- $28,535
- Report date
- 20 May 2026
- Price
- $1.08
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
BioXcel Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 52,500
- Estimated value
- $136
- Report date
- 04 May 2026
- Price
- $0.3523
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Richard I. Steinhart for BioXcel Therapeutics, Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.